Concepedia

Lingling Shan

LS

5

Publications

169

Citations

5

H-Index

2022

Active since

Affiliations

Institute of Hematology & Blood Diseases Hospital(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Union Hospital

Fujian Medical University

Beijing Tongren Hospital

Lingling Shan is an author at Institute of Hematology & Blood Diseases Hospital specializing in cell transplantation, medicine, and immunology.

Top concepts

Publications per year

2022–2024

5

Publications

5

Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia

Yue Tan, Lingling Shan, Liping Zhao et al. · Journal of Hematology & Oncology · 2023 · 75 citations · Full text

Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial

Jing Pan, Yue Tan, Lingling Shan et al. · Nature Medicine · 2024 · 36 citations

, , +9

C-JUN overexpressing CAR-T cells in acute myeloid leukemia: preclinical characterization and phase I trial

Shiyu Zuo, Chuo Li, Xiaolei Sun et al. · Nature Communications · 2024 · 27 citations · Full text

Phase I study of donor-derived CD5 CAR T cells in patients with relapsed or refractory T-cell acute lymphoblastic leukemia.

Jing Pan, Yue Tan, Lingling Shan et al. · Journal of Clinical Oncology · 2022 · 21 citations

, , +15

Sirt3 regulates NLRP3 and participates in the effects of plantainoside D on acute lung injury sepsis

Jing Wang, Wanrong Li, Fang Zhao et al. · Aging · 2023 · 10 citations · Full text

Rows per page

1–5 of 5